Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Frebus J. van Slochteren"'
Autor:
Philippe C. Wouters, MD, Frebus J. van Slochteren, PhD, Anton E. Tuinenburg, MD, PhD, Pieter A. Doevendans, MD, PhD, Maarten-Jan M. Cramer, MD, PhD, Peter-Paul H.M. Delnoy, MD, PhD, Vincent F. van Dijk, MD, PhD, Mathias Meine, MD, PhD
Publikováno v:
Heart Rhythm O2, Vol 4, Iss 1, Pp 9-17 (2023)
Background: Image guidance to assist left ventricular (LV) lead placement may improve outcome after cardiac resynchronization therapy (CRT), but previous approaches and results varied greatly, and multicenter feasibility is lacking altogether. Object
Externí odkaz:
https://doaj.org/article/97b2e5e72dd64ad6a2d87bc45c5aca70
Autor:
Frebus J van Slochteren, Chris van Lieshout, Maarten J Cramer, Philippe C Wouters, Vincent F van Dijk, Peter-Paul HM Delnoy, Pieter AFM Doevendans, Geert WJ Frederix, Mathias Meine
Publikováno v:
BMJ Open, Vol 11, Iss 10 (2021)
Introduction Achieving optimal placement of the left ventricular (LV) lead in cardiac resynchronisation therapy (CRT) is a prerequisite in order to achieve maximum clinical benefit, and is likely to help avoid non-response. Pacing outside scar tissue
Externí odkaz:
https://doaj.org/article/c6279ac86df8439ca07d42862797f398
Autor:
Maarten J. Cramer, Arco J. Teske, Pieter A. Doevendans, Karim Taha, Laurens P Bosman, Thomas P. Mast, Marijn H A Groen, Frebus J. van Slochteren, René van Es
Publikováno v:
Echocardiography (Mount Kisco, N.y.)
Background Different disease stages of arrhythmogenic right ventricular cardiomyopathy (ARVC) can be identified by right ventricle (RV) longitudinal deformation (strain) patterns. This requires assessment of the onset of shortening, (systolic) peak s
Autor:
Pieter A. Doevendans, Hans T. van den Broek, Rutger R. van de Leur, René van Es, Steven Wenker, Frebus J. van Slochteren, Steven A. J. Chamuleau
Publikováno v:
Journal of Cardiovascular Translational Research, 12(6), 517. Springer New York
Journal of Cardiovascular Translational Research
Journal of Cardiovascular Translational Research
Many cardiac catheter interventions require accurate discrimination between healthy and infarcted myocardia. The gold standard for infarct imaging is late gadolinium–enhanced MRI (LGE-MRI), but during cardiac procedures electroanatomical or electro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5632d2d9e92ccd72e2ca7335340d5f84
https://dspace.library.uu.nl/handle/1874/391372
https://dspace.library.uu.nl/handle/1874/391372
Autor:
Mira van der Naald, Steven A. J. Chamuleau, Frebus J. van Slochteren, Wouter A. Gathier, Pieter A. Doevendans, Dirk Jan van Ginkel
Publikováno v:
Journal of Cardiovascular Translational Research
Journal of Cardiovascular Translational Research, 11, 173. Springer New York
Journal of Cardiovascular Translational Research, 11, 173. Springer New York
An important aspect of cell therapy in the field of cardiac disease is safe and effective delivery of cells. Commonly used delivery strategies such as intramyocardial injection and intracoronary infusion both present with advantages and disadvantages
Autor:
Jeroen F. van der Heijden, Chris van Lieshout, Frebus J. van Slochteren, Steven Wenker, Steven A. J. Chamuleau, Geert W.J. Frederix, Peter Loh
Publikováno v:
Open Heart
Open Heart, 6(2). BMJ Publishing Group
Open Heart, 6(2). BMJ Publishing Group
Next to anticoagulation, pulmonary vein isolation (PVI) is the most important interventional procedure in the treatment of atrial fibrillation (AF). Despite widespread clinical application of this therapy, patients often require multiple procedures t
Autor:
Cheyenne C. S. Tseng, Frebus J. van Slochteren, Peter R. Seevinck, Adriaan O. Kraaijeveld, Maarten H. Bakker, Steven A. J. Chamuleau, Scott Kimmel, Jouke Smink, Steven Wenker, Patricia Y. W. Dankers
Publikováno v:
EuroIntervention, 15(4), E336-E339. EuroPCR
EuroIntervention, 15(4), e336. EuroPCR
EuroIntervention, 15(4), e336. EuroPCR
The MIGRATE (MrI Guided RegenerAtive ThErapy) consortium is a combined scientific and industrial effort to establish an MRIguided intramyocardial injection platform. By collaborating within the MIGRATE consortium we were able to combine state-of-thea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1e186198bbab3f0c00ed4c481df9ec8
https://research.tue.nl/nl/publications/53f813db-9792-4738-856f-306216ee3749
https://research.tue.nl/nl/publications/53f813db-9792-4738-856f-306216ee3749
Autor:
Anton E. Tuinenburg, Klaus Neef, Wouter A Gathier, John L. M. Bemelmans, Bas R van Klarenbosch, Joost P.G. Sluijter, Mira van der Naald, Pieter A. Doevendans, Steven A. J. Chamuleau, Frebus J. van Slochteren
Publikováno v:
BMJ Open Science
BMJ Open Science, Vol 3, Iss 1 (2019)
BMJ Open Science, 3(1):e000006. BMJ Publishing Group
BMJ Open Science, Vol 3, Iss 1 (2019)
BMJ Open Science, 3(1):e000006. BMJ Publishing Group
Background Commonly used strategies for cell delivery to the heart are intramyocardial injection and intracoronary (IC) infusion, both having their advantages and disadvantages. Therefore, alternative strategies, such as retrograde coronary venous in
Autor:
Peter R. Seevinck, Patricia Y. W. Dankers, Henk M. Janssen, Henk M. Keizer, Frebus J. van Slochteren, Maarten H. Bakker, Cheyenne C. S. Tseng, Steven A. J. Chamuleau
Publikováno v:
Advanced Healthcare Materials, 7(11):1701139. Wiley
Advanced Healthcare Materials, 7(11). John Wiley and Sons Ltd
Advanced Healthcare Materials, 7(11). John Wiley and Sons Ltd
Information about the in vivo location, shape, degradation, or erosion rate of injected in situ gelating hydrogels can be obtained with magnetic resonance imaging (MRI). Herein, an injectable supramolecular ureidopyrimidinone-based hydrogel (UPy-PEG)
Autor:
René van Es, Frebus J. van Slochteren, Leon de Jong, Hans T. van den Broek, Steven A. J. Chamuleau, Pieter A. Doevendans
Publikováno v:
Jove-Journal of visualized experiments, 2017(122). MYJoVE Corporation
Cardiac regenerative therapies aim to protect and repair the injured heart in patients with ischemic heart disease. By injecting stem cells or other biologicals that enhance angio- or vasculogenesis into the infarct border zone (IBZ), tissue perfusio